Success Metrics

Clinical Success Rate

87.5%

Based on 7 completed trials

Completion Rate

88%(7/8)

Active Trials

2(17%)

Results Posted

29%(2 trials)

Terminated

1(8%)

Phase Distribution

Ph phase_2

25%

Ph phase_3

Ph phase_4

Ph not_applicable

42%

Ph phase_1

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Phase 1Safety & dosage

1(9.1%)

Phase 2Efficacy & side effects

3(27.3%)

Phase 3Large-scale testing

1(9.1%)

Phase 4Post-market surveillance

1(9.1%)

N/ANon-phased studies

5(45.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(7)

Terminated(1)

Other(1)

Detailed Status

Completed7

Recruiting2

unknown1

Not yet recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

87.5%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (9.1%)

Phase 23 (27.3%)

Phase 31 (9.1%)

Phase 41 (9.1%)

N/A5 (45.5%)

Trials by Status

recruiting217%

unknown18%

not_yet_recruiting18%

terminated18%

completed758%

Recent Activity

2 active trials

Showing 5 of 12

completedphase_2

A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates

NCT06398808

recruitingnot_applicable

Maternal Mental Health Access - MaMa

NCT06049433

completednot_applicable

Brighter Bites & UT Physicians Produce Rx Program

NCT05556070

not_yet_recruitingphase_4

Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation

NCT06640738

recruiting

tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)

NCT05517135

View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials

NCT06398808Phase 2

A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates

Completed

NCT06049433Not Applicable

Maternal Mental Health Access - MaMa

Recruiting

NCT05556070Not Applicable

Brighter Bites & UT Physicians Produce Rx Program

Completed

NCT06640738Phase 4

Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation

Not Yet Recruiting

NCT05517135

tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)

Recruiting

NCT04268641Not Applicable

Evaluation of Positioning Protocols on a Wheelchair in Hemiplegic Patients

Completed

NCT02748707Phase 2

Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study

Unknown

NCT04804111Phase 2

Study of of URC102 to Assess the Efficacy and Safety in Gout Patients

Completed

NCT00742729Not Applicable

Increasing Colorectal Cancer Screening Among Filipino Americans

Completed

NCT00117806Not Applicable

Spinal Cord Injury Vocational Integration Program (SCI-VIP)

Completed

NCT01180062Phase 1

Safety Study of Latanoprost Slow Release Insert